Releases - Nutra Pharma Corporation

View:
 

Found press releases

 

Nutra Pharma Provides Sales and Marketing Update

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin™.
Coral Springs, FL. – December 20, 2012 - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is providing updates on the...

Nutra Pharma Introduces Nyloxin™ Military Strength

Nutra Pharma is introducing a stronger version of its over-the-counter (OTC) pain reliever, Nyloxin™, and has begun the process of registration with the United States government for sales into the military.
Coral Springs, FL. – December 19, 2012 - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has...

Nutra Pharma Letter to Shareholders

Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company
December 18, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the...

Nutra Pharma Begins Marketing Nyloxin™ Through Direct Distributors

Nutra Pharma announces the direct distribution of their Nyloxin™ line of pain relievers through TCN, a network of distributors in more than 20 countries.
September 20, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (Pink Sheets: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced...

Nutra Pharma Begins Affiliate Sales & Marketing Program for the Distribution of ...

Nutra Pharma announces the roll-out of a two-level, on-line affiliate sales and marketing plan for the sales and distribution of their Nyloxin™ line of pain relievers.
May 2, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain,...

Nutra Pharma Corporation

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, can...

View more


  CONTACT  
  • Nina Goldstein
  • 877-895-5647
  •